Shandong Sino-Agri United Biotechnology Co Ltd (SHE:003042) — Stock Price
Shandong Sino-Agri United Biotechnology Co Ltd (SHE:003042) is currently trading at CN¥13.40 CNY, up 2.68% today. Over the past 52 weeks, shares have ranged between CN¥11.37 and CN¥25.41. This page tracks Shandong Sino-Agri United Biotechnology Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Shandong Sino-Agri United Biotechnology (003042) total market value.
Shandong Sino-Agri United Biotechnology Co Ltd (003042) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Shandong Sino-Agri United Biotechnology Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Shandong Sino-Agri United Biotechnology Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Shandong Sino-Agri United Biotechnology Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥1.86 Billion | CN¥2.01 Billion | CN¥1.68 Billion | CN¥1.93 Billion | CN¥1.63 Billion |
| Cost of Revenue | CN¥1.67 Billion | CN¥1.85 Billion | CN¥1.60 Billion | CN¥1.57 Billion | CN¥1.26 Billion |
| Gross Profit | CN¥194.72 Million | CN¥159.99 Million | CN¥81.95 Million | CN¥361.73 Million | CN¥361.29 Million |
| Research & Development | CN¥78.82 Million | CN¥86.61 Million | CN¥98.48 Million | CN¥103.91 Million | CN¥73.63 Million |
| SG&A | CN¥58.74 Million | CN¥116.93 Million | CN¥131.03 Million | CN¥113.52 Million | CN¥102.10 Million |
| Total Operating Expenses | CN¥1.97 Billion | CN¥295.60 Million | CN¥319.19 Million | CN¥290.04 Million | CN¥252.35 Million |
| Operating Income | CN¥-110.47 Million | CN¥-135.61 Million | CN¥-237.24 Million | CN¥71.69 Million | CN¥108.93 Million |
| EBITDA | — | CN¥84.22 Million | CN¥-35.10 Million | CN¥251.93 Million | CN¥249.07 Million |
| EBIT | — | CN¥-91.17 Million | CN¥-199.97 Million | CN¥99.81 Million | CN¥135.03 Million |
| Interest Expense | CN¥36.33 Million | CN¥45.03 Million | CN¥36.62 Million | CN¥28.77 Million | CN¥26.13 Million |
| Income Before Tax | CN¥-161.59 Million | CN¥-136.20 Million | CN¥-236.60 Million | CN¥71.03 Million | CN¥108.90 Million |
| Income Tax Expense | — | CN¥-13.75 Million | CN¥-44.12 Million | CN¥-2.10 Million | CN¥10.31 Million |
| Net Income | CN¥-136.61 Million | CN¥-122.45 Million | CN¥-192.47 Million | CN¥73.14 Million | CN¥98.59 Million |
Shandong Sino-Agri United Biotechnology Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Shandong Sino-Agri United Biotechnology Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥3.82 Billion | CN¥3.93 Billion | CN¥3.74 Billion | CN¥3.54 Billion | CN¥3.22 Billion |
| Total Current Assets | CN¥1.29 Billion | CN¥1.40 Billion | CN¥1.50 Billion | CN¥1.67 Billion | CN¥1.65 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | CN¥328.05 Million | CN¥315.18 Million | CN¥212.46 Million | CN¥350.52 Million | CN¥224.56 Million |
| Inventory | CN¥550.74 Million | CN¥502.13 Million | CN¥563.19 Million | CN¥593.54 Million | CN¥410.49 Million |
| Property, Plant & Equipment | — | — | — | — | CN¥1.32 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CN¥2.60 Billion | CN¥2.58 Billion | CN¥2.27 Billion | CN¥1.86 Billion | CN¥1.59 Billion |
| Total Current Liabilities | CN¥2.31 Billion | CN¥1.97 Billion | CN¥1.73 Billion | CN¥1.57 Billion | CN¥1.34 Billion |
| Long-term Debt | CN¥142.83 Million | CN¥417.28 Million | CN¥369.10 Million | CN¥240.15 Million | CN¥240.35 Million |
| Net Debt | CN¥625.11 Million | CN¥503.21 Million | CN¥228.81 Million | CN¥255.13 Million | CN¥-55.37 Million |
| Total Stockholder Equity | CN¥1.22 Billion | CN¥1.35 Billion | CN¥1.47 Billion | CN¥1.68 Billion | CN¥1.63 Billion |
| Retained Earnings | CN¥216.08 Million | CN¥353.21 Million | CN¥475.66 Million | CN¥683.22 Million | CN¥632.65 Million |
Shandong Sino-Agri United Biotechnology Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Shandong Sino-Agri United Biotechnology Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥13.86 Million | CN¥104.90 Million | CN¥86.90 Million | CN¥-40.39 Million | CN¥54.41 Million |
| Capital Expenditures | CN¥129.50 Million | CN¥174.70 Million | CN¥134.93 Million | CN¥129.15 Million | CN¥244.90 Million |
| Free Cash Flow | CN¥-115.64 Million | CN¥-69.81 Million | CN¥-48.03 Million | CN¥-169.54 Million | CN¥-190.49 Million |
| Investing Cash Flow | — | CN¥-322.39 Million | CN¥-274.01 Million | CN¥-219.65 Million | CN¥-334.89 Million |
| Financing Cash Flow | — | CN¥70.61 Million | CN¥417.26 Million | CN¥-1.48 Million | CN¥492.25 Million |
| Dividends Paid | CN¥20.16 Million | CN¥25.13 Million | CN¥35.24 Million | CN¥21.92 Million | CN¥20.10 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥218.82 Million | CN¥176.16 Million | CN¥166.18 Million | CN¥152.34 Million | CN¥114.16 Million |
| Change in Cash | CN¥-205.71 Million | CN¥-138.58 Million | CN¥231.57 Million | CN¥-259.51 Million | CN¥213.30 Million |
Shandong Sino-Agri United Biotechnology Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Shandong Sino-Agri United Biotechnology Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | -0.34 | — | — |
| Jun 30, 2025 | -0.01 | — | — |
| Mar 31, 2025 | 0.03 | — | — |
| Dec 31, 2024 | -0.47 | — | — |
| Sep 30, 2024 | -0.16 | — | — |
| Jun 30, 2024 | -0.08 | — | — |
| Mar 31, 2024 | -0.15 | — | — |
| Dec 31, 2023 | -0.75 | — | — |